| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Tax Preparation Fee | 1,200 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempco | 2012-04 | D | 2012-06 | 20,000 | 10,000 | 10,000 | ||||
| Oncologix | 2012-08 | D | 2012-12 | 28,798 | 32,727 | -3,929 | ||||
| CPCM | 2012-09 | D | 2012-12 | 7,249 | 7,070 | 179 |
| Identifier | Return Reference | Explanation |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 23961 shares of Coda Octopus | 2,434 | 1,914 |
| 28000 shares of Grandparents | 8,800 | 8,400 |
| Item No. | 1 |
|---|---|
| Lender's Name | Harry Silverman |
| Lender's Title | |
| Original Amount of Loan | 45744 |
| Balance Due | 4000 |
| Date of Note | 2010-12 |
| Maturity Date | 2012-12 |
| Repayment Terms | DEMAND |
| Interest Rate | |
| Security Provided by Borrower | NONE |
| Purpose of Loan | Capital For the Foundation |
| Description of Lender Consideration | |
| Consideration FMV |
| Description | Amount |
|---|---|
| FMV of Stock | 101 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Bank Fee | 192 | |||
| Consulting Fee | 4,400 | |||
| Secretarial | 400 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Legal Fee | 252 |